M. Saltzman

Pharmacokinetics of a Rivastigmine Transdermal Patch Formulation in Healthy Volunteers: Relative Effects of Body Site Application

B. Kiese, G. Sedek, G. Lefèvre, 2007, Journal of clinical pharmacology.

Effect of a Nutritional Supplement on Posaconazole Pharmacokinetics following Oral Administration to Healthy Volunteers

G. Krishna, B. Kantesaria, Mitchell Rosenberg, 2006, Antimicrobial Agents and Chemotherapy.

A phase I dose-escalation study of the safety, pharmacokinetics (PK), and pharmacodynamics (PD) of SCH 727965, a novel cyclin-dependent kinase inhibitor, administered weekly in subjects with advanced malignancies.

J. Nemunaitis, P. Kirschmeier, D. Khaira, 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Proactive strategies for regorafenib in metastatic colorectal cancer: implications for optimal patient management

F. Braiteh, R. Moss, G. Khan, 2014, Cancer Management and Research.

The selective sphingosine 1-phosphate receptor modulator BAF312 redirects lymphocyte distribution and has species-specific effects on heart rate

N. Gray, T. Sing, B. Nuesslein-Hildesheim, 2012, British journal of pharmacology.

Pharmacokinetics of Intravenous Cefotaxime in Patients Undergoing Chronic Hemodialysis

H. Neu, M. Saltzman, E. Francke, 1981, Therapeutic drug monitoring.

Cancer Management and Research Dovepress Proactive Strategies for Regorafenib in Metastatic Colorectal Cancer: Implications for Optimal Patient Management

F. Braiteh, R. Moss, G. Khan, 2022 .